UCBG intergroup: 3-years efficacy results of the Unicancer-PACS08 trial including poor prognosis patients treated with docetaxel or ixabepilone in adjuvant setting

Affiliation auteurs!!!! Error affiliation !!!!
TitreUCBG intergroup: 3-years efficacy results of the Unicancer-PACS08 trial including poor prognosis patients treated with docetaxel or ixabepilone in adjuvant setting
Type de publicationJournal Article
Year of Publication2016
AuteursCampone M., Lacroix-Triki M., Roca L., Spielmann M., Wildiers H., Cottu P., Kerbrat P., Levy C., Mayer F., Bachelot T., Wiston T., Eymard J-C, Uwer L., Machiels J-P, Verhoeven D., Jaubert D., Facchini T., Orfeuvre H., Canon J-L, Asselain B., Lemonnier J., Roche H.
JournalCANCER RESEARCH
Volume76
Date PublishedFEB 15
Type of ArticleMeeting Abstract
ISSN0008-5472
DOI10.1158/1538-7445.SABCS15-P1-12-06